Cargando…
Financing repurposed drugs for rare diseases: a case study of Unravel Biosciences
BACKGROUND: We consider two key challenges that early-stage biotechnology firms face in developing a sustainable financing strategy and a sustainable business model: developing a valuation model for drug compounds, and choosing an appropriate operating model and corporate structure. We use the speci...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496212/ https://www.ncbi.nlm.nih.gov/pubmed/37700316 http://dx.doi.org/10.1186/s13023-023-02753-y |